218 related articles for article (PubMed ID: 35569515)
1. Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States.
Fang NZ; Westhoff CL
Am J Obstet Gynecol; 2022 Sep; 227(3):477.e1-477.e7. PubMed ID: 35569515
[TBL] [Abstract][Full Text] [Related]
2. Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
Moniz MH; Chang T; Heisler M; Admon L; Gebremariam A; Dalton VK; Davis MM
Obstet Gynecol; 2017 Jun; 129(6):1078-1085. PubMed ID: 28486357
[TBL] [Abstract][Full Text] [Related]
3. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with postpartum use of long-acting reversible contraception.
Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
[TBL] [Abstract][Full Text] [Related]
5. Contraception and sterilization selection at delivery among pregnant patients with malignancy.
Harris CA; Mandelbaum RS; Rau AR; Song BB; Klar M; Ouzounian JG; Paulson RJ; Roman LD; Matsuo K
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):695-706. PubMed ID: 37578024
[TBL] [Abstract][Full Text] [Related]
6. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
Eggebroten JL; Sanders JN; Turok DK
Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
[TBL] [Abstract][Full Text] [Related]
7. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
8. Changes in Rates of Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the USA, 2012-2016.
Sheyn D; Arora KS
Matern Child Health J; 2021 Oct; 25(10):1562-1573. PubMed ID: 33970416
[TBL] [Abstract][Full Text] [Related]
9. Obstetrics-gynecology resident long-acting reversible contraception training: the role of resident and program characteristics.
Maples JM; Espey E; Evans ML; Breeze JL; Ogburn T; Zite NB
Am J Obstet Gynecol; 2020 Apr; 222(4S):S923.e1-S923.e8. PubMed ID: 31866517
[TBL] [Abstract][Full Text] [Related]
10. Postpartum intrauterine device insertion and postpartum tubal sterilization in the United States.
Whiteman MK; Cox S; Tepper NK; Curtis KM; Jamieson DJ; Penman-Aguilar A; Marchbanks PA
Am J Obstet Gynecol; 2012 Feb; 206(2):127.e1-7. PubMed ID: 21963310
[TBL] [Abstract][Full Text] [Related]
11. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
12. Coverage of immediate postpartum long-acting reversible contraception has improved birth intervals for at-risk populations.
Liberty A; Yee K; Darney BG; Lopez-Defede A; Rodriguez MI
Am J Obstet Gynecol; 2020 Apr; 222(4S):S886.e1-S886.e9. PubMed ID: 31846612
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
14. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
Paul R; Huysman BC; Maddipati R; Madden T
Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
[TBL] [Abstract][Full Text] [Related]
15. Trends in contraceptive use according to HIV status among privately insured women in the United States.
Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
[TBL] [Abstract][Full Text] [Related]
16. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
[TBL] [Abstract][Full Text] [Related]
17. Provision of immediate postpartum contraception to women living with HIV in the Eastern Cape, South Africa; a cross-sectional analysis.
Adeniyi OV; Ajayi AI; Somefun OD; Lambert JS
Reprod Health; 2020 Dec; 17(1):194. PubMed ID: 33298097
[TBL] [Abstract][Full Text] [Related]
18. Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.
Moniz MH; Peahl AF; Fendrick AM; Kolenic GE; Tilea A; Wetmore M; Dalton VK
Am J Obstet Gynecol; 2021 Mar; 224(3):282.e1-282.e17. PubMed ID: 32898503
[TBL] [Abstract][Full Text] [Related]
19. Motivational interviewing to promote long-acting reversible contraception among Rwandan couples wishing to prevent or delay pregnancy.
Mukamuyango J; Ingabire R; Parker R; Nyombayire J; Easter SR; Wall KM; Tichacek A; Nyirazinyoye L; Kaslow N; Allen S; Karita E
Am J Obstet Gynecol; 2020 Apr; 222(4S):S919.e1-S919.e12. PubMed ID: 31838122
[TBL] [Abstract][Full Text] [Related]
20. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
Diedrich JT; Klein DA; Peipert JF
Am J Obstet Gynecol; 2017 Apr; 216(4):364.e1-364.e12. PubMed ID: 28038902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
